Login / Signup

Antimicrobials in polymethylmethacrylate: from prevention to prosthetic joint infection treatment: basic principles and risk of resistance.

Marta Sabater-MartosMiguel A VerdejoLaura MorataErnesto Muñoz-MahamudErnesto Guerra-FarfanJuan C Martinez-PastorAlex Soriano
Published in: Arthroplasty (London, England) (2023)
While waiting for better evidence from well-designed clinical trials, ALBC shows a beneficial effect as a prophylaxis in arthroplasty, and to avoid the colonization of spacers used for two-stage revision in patients with PJI. Experimental models and clinical evidence suggest the need to achieve high local antimicrobial concentrations to obtain the highest prophylactic and therapeutic effect. The current evidence does not support the risk of increasing resistance with use of ALBC. In the future, it is necessary to evaluate new carriers and different antimicrobials to improve clinical outcomes.
Keyphrases
  • clinical trial
  • total knee arthroplasty
  • staphylococcus aureus
  • current status
  • randomized controlled trial
  • replacement therapy
  • phase iii